Back to Home

ECL

🔒 LOCKED

Ecolab Inc.

Current Price
$273.11
Confidence Score
85%
🔒 LOCKED
Intrinsic Value
$120.50
🔒 LOCKED
Cache Age
987 hours ago

🔒 Unlock Full Analysis

Sign in and use 1 credit to see AI verdict, intrinsic value, SWOT analysis, and all premium insights.

AI Executive Summary

Ecolab is a leading provider of water, hygiene, and infection prevention solutions, but its high valuation warrants a cautious approach despite strong fundamentals.

The Business DNA

Headline: The Business DNA. Ecolab Inc. (ECL) is a global leader in water, hygiene, and infection prevention solutions and services. Its core business revolves around providing essential products and services to a diverse range of industries, including manufacturing, food and beverage processing, healthcare, hospitality, and energy. Ecolab's value proposition centers on helping its customers improve operational efficiency, enhance product quality, ensure workplace safety, and minimize environmental impact. The company's solutions encompass water treatment, cleaning and sanitizing, pest elimination, and infection prevention. Ecolab's business model is characterized by long-term customer relationships, recurring revenue streams, and a strong focus on innovation. The company invests heavily in research and development to develop new and improved products and services that address the evolving needs of its customers. Ecolab's global reach and extensive service network provide it with a significant competitive advantage. The company operates in over 170 countries and has a team of highly trained service professionals who provide on-site support to customers. This local presence allows Ecolab to tailor its solutions to meet the specific needs of each customer and to provide timely and effective service. Ecolab's commitment to sustainability is also a key differentiator. The company helps its customers reduce their water and energy consumption, minimize waste, and improve their environmental performance. This focus on sustainability resonates with customers who are increasingly concerned about their environmental footprint. The company's four reportable segments – Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination – are strategically aligned to serve specific customer needs and market segments. This segmentation allows Ecolab to develop specialized solutions and expertise within each area, further enhancing its competitive position. The company's ability to adapt to changing market conditions and customer demands is crucial for its long-term success. Ecolab's history of innovation and its commitment to providing value-added solutions have enabled it to maintain its leadership position in the industry. The company's strong brand reputation and its focus on customer satisfaction are also important factors in its success.

Financial Health

Valuation Analysis

Headline: Valuation Check. Ecolab's current price of $282.42 is trading near its 52-week high of $286.04, suggesting that the stock has experienced significant upward momentum. The analyst target mean price of $295.38095 indicates that analysts expect the stock to appreciate further. However, it's crucial to analyze the valuation metrics in detail to determine if the current price is justified. The company's price-to-earnings (P/E) ratio of 40.635975 is relatively high compared to the average P/E ratio of the S&P 500, which suggests that the stock may be overvalued. However, Ecolab's forward P/E ratio of 33.322517 is lower than its trailing P/E ratio, indicating that analysts expect its earnings to grow in the future. The company's price-to-sales (P/S) ratio of 5.040864 is also relatively high, which may indicate that the stock is overvalued. However, Ecolab's strong brand reputation and its focus on customer satisfaction may justify a premium valuation. The company's price-to-book (P/B) ratio of 12.03939 is also relatively high, which may indicate that the stock is overvalued. However, Ecolab's high return on equity (ROE) of 21.869% may justify a premium valuation. Ecolab's PEG ratio is not available, which makes it difficult to assess the company's valuation relative to its growth rate. However, the company's revenue growth of 17.8% suggests that it has strong growth prospects. Considering the recent news, Erste Group lowered its rating on Ecolab to Hold from Buy due to valuation concerns, highlighting that Ecolab's P/E multiple sits well above sector averages. This suggests that the market may be pricing in excessive optimism regarding Ecolab's future growth. However, other analysts expect Ecolab's earnings to grow, which could justify the current valuation. Overall, Ecolab's valuation appears to be stretched, with high P/E, P/S, and P/B ratios. Investors should carefully consider the company's growth prospects and profitability before making an investment decision. A discounted cash flow (DCF) analysis would be helpful to determine the intrinsic value of the stock. Furthermore, comparing Ecolab's valuation metrics to those of its competitors would provide valuable insights.

Risks & Catalysts

Final Verdict: 🔒 LOCKED

Confidence Score
0%
Intrinsic Value
$🔒 LOCKED

Want More AI-Powered Analysis?

Get unlimited stock analyses, portfolio tracking, and real-time alerts

Related Stock Analyses

This analysis is generated by AI and should not be considered financial advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Last updated: 3/16/2026

ECL Analysis: 🔒 LOCKED (0% Confidence) | Tamtech Finance